295 related articles for article (PubMed ID: 21321303)
1. Handle region peptide counteracts the beneficial effects of the Renin inhibitor aliskiren in spontaneously hypertensive rats.
van Esch JH; van Veghel R; Garrelds IM; Leijten F; Bouhuizen AM; Danser AH
Hypertension; 2011 Apr; 57(4):852-8. PubMed ID: 21321303
[TBL] [Abstract][Full Text] [Related]
2. Beneficial cardiac effects of the renin inhibitor aliskiren in spontaneously hypertensive rats.
van Esch JH; Moltzer E; van Veghel R; Garrelds IM; Leijten F; Bouhuizen AM; Danser AH
J Hypertens; 2010 Oct; 28(10):2145-55. PubMed ID: 20625318
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic and hormonal changes to dual renin-angiotensin system inhibition in experimental hypertension.
Moniwa N; Varagic J; Ahmad S; VonCannon JL; Simington SW; Wang H; Groban L; Brosnihan KB; Nagata S; Kato J; Kitamura K; Gomez RA; Lopez ML; Ferrario CM
Hypertension; 2013 Feb; 61(2):417-24. PubMed ID: 23232645
[TBL] [Abstract][Full Text] [Related]
4. Aliskiren, a novel, orally effective renin inhibitor, lowers blood pressure in marmosets and spontaneously hypertensive rats.
Wood JM; Schnell CR; Cumin F; Menard J; Webb RL
J Hypertens; 2005 Feb; 23(2):417-26. PubMed ID: 15662231
[TBL] [Abstract][Full Text] [Related]
5. Aliskiren reduces myocardial ischemia-reperfusion injury by a bradykinin B2 receptor- and angiotensin AT2 receptor-mediated mechanism.
Koid SS; Ziogas J; Campbell DJ
Hypertension; 2014 Apr; 63(4):768-73. PubMed ID: 24420538
[TBL] [Abstract][Full Text] [Related]
6. Long-term antihypertensive effects of aliskiren, a direct renin inhibitor, in chronic hemodialysis patients.
Ishimitsu T; Ohta S; Ohno E; Takahashi T; Numabe A; Okamura A; Ohba S; Hashimoto A; Matsuoka H
Ther Apher Dial; 2013 Oct; 17(5):524-31. PubMed ID: 24107281
[TBL] [Abstract][Full Text] [Related]
7. The putative (pro)renin receptor blocker HRP fails to prevent (pro)renin signaling.
Feldt S; Maschke U; Dechend R; Luft FC; Muller DN
J Am Soc Nephrol; 2008 Apr; 19(4):743-8. PubMed ID: 18235083
[TBL] [Abstract][Full Text] [Related]
8. Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertension.
Dietz R; Dechend R; Yu CM; Bheda M; Ford J; Prescott MF; Keefe DL
J Renin Angiotensin Aldosterone Syst; 2008 Sep; 9(3):163-75. PubMed ID: 18957387
[TBL] [Abstract][Full Text] [Related]
9. Persistent antihypertensive effect of aliskiren is accompanied by reduced proteinuria and normalization of glomerular area in Ren-2 transgenic rats.
Rakusan D; Kujal P; Kramer HJ; Husková Z; Vanourková Z; Vernerová Z; Mrázová I; Thumová M; Cervenka L; Vanecková I
Am J Physiol Renal Physiol; 2010 Oct; 299(4):F758-66. PubMed ID: 20668096
[TBL] [Abstract][Full Text] [Related]
10. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
Horký K
Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
[TBL] [Abstract][Full Text] [Related]
11. Deterioration of kidney function by the (pro)renin receptor blocker handle region peptide in aliskiren-treated diabetic transgenic (mRen2)27 rats.
te Riet L; van den Heuvel M; Peutz-Kootstra CJ; van Esch JH; van Veghel R; Garrelds IM; Musterd-Bhaggoe U; Bouhuizen AM; Leijten FP; Danser AH; Batenburg WW
Am J Physiol Renal Physiol; 2014 May; 306(10):F1179-89. PubMed ID: 24694588
[TBL] [Abstract][Full Text] [Related]
12. The (pro)renin receptor blocker handle region peptide upregulates endothelium-derived contractile factors in aliskiren-treated diabetic transgenic (mREN2)27 rats.
Batenburg WW; van den Heuvel M; van Esch JH; van Veghel R; Garrelds IM; Leijten F; Danser AH
J Hypertens; 2013 Feb; 31(2):292-302. PubMed ID: 23303354
[TBL] [Abstract][Full Text] [Related]
13. [The future of renin inhibition].
Uresin AY; Baran E
Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
[TBL] [Abstract][Full Text] [Related]
14. Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes.
Imanishi T; Tsujioka H; Ikejima H; Kuroi A; Takarada S; Kitabata H; Tanimoto T; Muragaki Y; Mochizuki S; Goto M; Yoshida K; Akasaka T
Hypertension; 2008 Sep; 52(3):563-72. PubMed ID: 18645051
[TBL] [Abstract][Full Text] [Related]
15. Restoration of the blood pressure circadian rhythm by direct renin inhibition and blockade of angiotensin II receptors in mRen2.Lewis hypertensive rats.
Moniwa N; Varagic J; Ahmad S; VonCannon JL; Ferrario CM
Ther Adv Cardiovasc Dis; 2012 Feb; 6(1):15-29. PubMed ID: 22222314
[TBL] [Abstract][Full Text] [Related]
16. Renin inhibition by aliskiren prevents atherosclerosis progression: comparison with irbesartan, atenolol, and amlodipine.
Nussberger J; Aubert JF; Bouzourene K; Pellegrin M; Hayoz D; Mazzolai L
Hypertension; 2008 May; 51(5):1306-11. PubMed ID: 18391092
[TBL] [Abstract][Full Text] [Related]
17. Aliskiren increases bradykinin and tissue kallikrein mRNA levels in the heart.
Campbell DJ; Zhang Y; Kelly DJ; Gilbert RE; McCarthy DJ; Shi W; Smyth GK
Clin Exp Pharmacol Physiol; 2011 Sep; 38(9):623-31. PubMed ID: 21736602
[TBL] [Abstract][Full Text] [Related]
18. Direct renin inhibition with aliskiren protects against myocardial ischemia/reperfusion injury by activating nitric oxide synthase signaling in spontaneously hypertensive rats.
Zhang W; Han Y; Meng G; Bai W; Xie L; Lu H; Shao Y; Wei L; Pan S; Zhou S; Chen Q; Ferro A; Ji Y
J Am Heart Assoc; 2014 Jan; 3(1):e000606. PubMed ID: 24473199
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of aliskiren-based and ramipril-based therapy on the renin system during long-term (6 months) treatment and withdrawal in patients with hypertension.
Andersen K; Weinberger MH; Constance CM; Ali MA; Jin J; Prescott MF; Keefe DL
J Renin Angiotensin Aldosterone Syst; 2009 Sep; 10(3):157-67. PubMed ID: 19617271
[TBL] [Abstract][Full Text] [Related]
20. Combined renin inhibition/(pro)renin receptor blockade in diabetic retinopathy--a study in transgenic (mREN2)27 rats.
Batenburg WW; Verma A; Wang Y; Zhu P; van den Heuvel M; van Veghel R; Danser AH; Li Q
PLoS One; 2014; 9(6):e100954. PubMed ID: 24968134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
